{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:29:42Z","timestamp":1778858982010,"version":"3.51.4"},"reference-count":38,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the Swedish Research Council for Health, Working Life and Welfare","award":["2007-1762"],"award-info":[{"award-number":["2007-1762"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis Journal - Experimental, Translational and Clinical"],"published-print":{"date-parts":[[2018,7]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p> Population-based estimates of costs of illness and health-related quality of life, by disability levels among people with multiple sclerosis, are lacking. <\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p> To estimate the annual costs of illness and health-related quality of life, by disability levels, among multiple sclerosis patients, 21\u201364 years of age. <\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p> Microdata from Swedish nationwide registers were linked to estimate the prevalence-based costs of illness in 2013, including direct costs (prescription drug use and specialised healthcare) and indirect costs (calculated using sick leave and disability pension), and health-related quality of life (estimated from the EQ-5D). Disability level was measured by the Expanded Disability Status Scale (EDSS). <\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p> Among 8906 multiple sclerosis patients, EDSS 0.0\u20133.5 and 7.0\u20139.5 were associated with mean indirect costs of SEK 117,609 and 461,357, respectively, whereas direct costs were similar between the categories (SEK 117,423 and 102,714, respectively). Prescription drug costs represented 40% of the costs of illness among multiple sclerosis patients with low EDSS, while among patients with high EDSS more than 80% were indirect costs. Among the 1684 individuals who had reported both EQ-5D and EDSS, the lowest health-related quality of life scores were found among those with a high EDSS. <\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p> Among people with multiple sclerosis, we confirmed higher costs and lower health-related quality of life in higher disability levels, in particular high indirect costs. <\/jats:p><\/jats:sec>","DOI":"10.1177\/2055217318783352","type":"journal-article","created":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T13:39:38Z","timestamp":1531143578000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":11,"title":["Costs and quality of life by disability among people with multiple sclerosis: a register-based study in Sweden"],"prefix":"10.1177","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6890-5162","authenticated-orcid":false,"given":"Hanna","family":"Gyllensten","sequence":"first","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Sweden"},{"name":"Centre for Person-centred Care (GPCC) and Institute of Health and Care Sciences, University of Gothenburg, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3896-7332","authenticated-orcid":false,"given":"Andrius","family":"Kavaliunas","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Alexanderson","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Hillert","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Sweden"},{"name":"Department of Research and Education, Karolinska University Hospital, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petter","family":"Tingh\u00f6g","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Sweden"},{"name":"Department of Public Health and Medicine, Red Cross University College, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilie","family":"Friberg","sequence":"additional","affiliation":[{"name":"Department of Clinical Neuroscience, Karolinska Institutet, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2018,7,9]]},"reference":[{"key":"bibr1-2055217318783352","volume-title":"Gene Reviews (R)","author":"St\u00fcve O","year":"1993"},{"key":"bibr2-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1016\/j.euroneuro.2011.08.008"},{"key":"bibr3-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2011.03590.x"},{"key":"bibr4-2055217318783352","unstructured":"Segel JE. Cost-of-Illness Studies \u2013 A Primer. RTI-UNC Center of Excellence in Health Promotion Economics\/RTI International, Research Triangle Park, NC, USA, January 2006."},{"key":"bibr5-2055217318783352","unstructured":"Trisolini M, Honeycutt A, Wiener J, et\u00a0al. Global economic impact of multiple sclerosis. RTI International, May 2010.Research Triangle Park, NC, USA."},{"key":"bibr6-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514566419"},{"key":"bibr7-2055217318783352","doi-asserted-by":"publisher","DOI":"10.3988\/jcn.2015.11.1.9"},{"key":"bibr8-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159129"},{"key":"bibr9-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1586\/14737167.6.2.145"},{"key":"bibr10-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1191\/1352458505ms1137oa"},{"key":"bibr11-2055217318783352","doi-asserted-by":"publisher","DOI":"10.2165\/11532230-000000000-00000"},{"key":"bibr12-2055217318783352","doi-asserted-by":"publisher","DOI":"10.3111\/13696990903543085"},{"key":"bibr13-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514564491"},{"key":"bibr14-2055217318783352","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2015.1086362"},{"key":"bibr15-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-006-0431-5"},{"key":"bibr16-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1111\/ane.12425"},{"key":"bibr17-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515570767"},{"key":"bibr18-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.33.11.1444"},{"key":"bibr19-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-14-58"},{"key":"bibr20-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1294"},{"key":"bibr21-2055217318783352","unstructured":"The Dental and Pharmaceutical Benefits Agency. TLV, database of drug prices. https:\/\/www.tlv.se\/in-english\/medicines.html (2012, accessed 19 June 2018)."},{"key":"bibr22-2055217318783352","unstructured":"The National Board of Health and Welfare. National DRG weights. www.socialstyrelsen.se\/klassificeringochkoder\/norddrg\/vikter (2014, accessed 1 June 2015)."},{"key":"bibr23-2055217318783352","unstructured":"Karlsson \u00c5, Serd\u00e9n L. V\u00e5rdkostnader 2013 f\u00f6r NordDRG: en sammanst\u00e4llning av material fr\u00e5n den nationella kostnadsdatabasen. The National Board of Health and Welfare; The Swedish Association of Local Authorities and Regions, 2015."},{"key":"bibr24-2055217318783352","unstructured":"Statistik om h\u00e4lso- och sjukv\u00e5rd samt regional utveckling 2013. Swedish Association of Local Authorities and Regions, August 2014."},{"key":"bibr25-2055217318783352","unstructured":"Knutsson H. Patientavgifter fr.o.m. den 1 januari 2013 [Patient fees from 1 Jan 2013]. The Swedish Association of Local Authorities and Regions, 01\/11 2013."},{"key":"bibr26-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-013-0496-4"},{"key":"bibr27-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1177\/1403494815596910"},{"key":"bibr28-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200205000-00009"},{"key":"bibr29-2055217318783352","doi-asserted-by":"crossref","unstructured":"Kobelt G, Thompson A, Berg J, et\u00a0al. New insights into the burden and costs of multiple sclerosis in Europe. Mult Scler.\u00a02017; 23: 1123\u20131136. DOI:10.1177\/1352458517694432","DOI":"10.1177\/1352458517694432"},{"key":"bibr30-2055217318783352","unstructured":"NordDRG Users\u2019 Manual Version 2012 SWE PR1b. http:\/\/www.norddrg.net\/norddrgmanual\/NordDRG_2012_SWE\/index.htm (2012, accessed 24 March 2016)."},{"key":"bibr31-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1016\/0167-6296(94)00044-5"},{"key":"bibr32-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-6296(97)00006-4"},{"key":"bibr33-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2007.00192.x"},{"key":"bibr34-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-14-115"},{"key":"bibr35-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1177\/1352458511403794"},{"key":"bibr36-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517708682"},{"key":"bibr37-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1177\/1352458517708097"},{"key":"bibr38-2055217318783352","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-017-0894-6"}],"container-title":["Multiple Sclerosis Journal - Experimental, Translational and Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2055217318783352","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2055217318783352","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2055217318783352","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T09:38:08Z","timestamp":1740821888000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2055217318783352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["10.1177\/2055217318783352"],"URL":"https:\/\/doi.org\/10.1177\/2055217318783352","relation":{},"ISSN":["2055-2173","2055-2173"],"issn-type":[{"value":"2055-2173","type":"print"},{"value":"2055-2173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7]]},"article-number":"2055217318783352"}}